Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 3
1986 6
1987 4
1988 7
1989 4
1990 4
1991 5
1992 4
1993 5
1994 4
1995 6
1996 14
1997 16
1998 14
1999 29
2000 25
2001 23
2002 32
2003 40
2004 39
2005 40
2006 69
2007 71
2008 63
2009 102
2010 135
2011 152
2012 167
2013 177
2014 193
2015 236
2016 241
2017 284
2018 304
2019 373
2020 457
2021 506
2022 576
2023 576
2024 581
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,038 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Nrf2 to treat thyroid cancer.
Gong Z, Xue L, Li H, Fan S, van Hasselt CA, Li D, Zeng X, Tong MCF, Chen GG. Gong Z, et al. Among authors: xue l. Biomed Pharmacother. 2024 Apr;173:116324. doi: 10.1016/j.biopha.2024.116324. Epub 2024 Feb 28. Biomed Pharmacother. 2024. PMID: 38422655 Free article. Review.
Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.
Lin S, Dai Y, Han C, Han T, Zhao L, Wu R, Liu J, Zhang B, Huang N, Liu Y, Lai S, Shi J, Wang Y, Lou M, Xie J, Cheng Y, Tang H, Yao H, Fang H, Zhang Y, Wu X, Shen L, Ye Y, Xue L, Wu ZB. Lin S, et al. Among authors: xue l. Genome Med. 2024 Apr 24;16(1):60. doi: 10.1186/s13073-024-01325-4. Genome Med. 2024. PMID: 38658971 Free PMC article.
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.
Qin J, Xue L, Hao A, Guo X, Jiang T, Ni Y, Liu S, Chen Y, Jiang H, Zhang C, Kang M, Lin J, Li H, Li C, Tian H, Li L, Fu J, Zhang Y, Ma J, Wang X, Fu M, Yang H, Yang Z, Han Y, Chen L, Tan L, Dai T, Liao Y, Zhang W, Li B, Chen Q, Guo S, Qi Y, Wei L, Li Z, Tian Z, Kang X, Zhang R, Li Y, Wang Z, Chen X, Hou Z, Zheng R, Zhu W, He J, Li Y. Qin J, et al. Among authors: xue l. Nat Med. 2024 Sep;30(9):2549-2557. doi: 10.1038/s41591-024-03064-w. Epub 2024 Jul 2. Nat Med. 2024. PMID: 38956195 Free PMC article. Clinical Trial.
5,038 results